Hillhouse Capital Advisors »

Contineum Therapeutics shares owned by Hillhouse Capital Advisors

Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by Hillhouse Capital Advisors from 13F filings

Historical chart of Hillhouse Capital Advisors investment in Contineum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Contineum Therapeutics held by Hillhouse Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Contineum Therapeutics by Hillhouse Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $7.9M 669k 11.75
2025-06-30 $2.7M 669k 3.97
2025-03-31 $4.7M 669k 6.98
2024-12-31 $9.8M 669k 14.65
2024-09-30 $13M 669k 19.14
2024-06-30 $12M 669k 17.61

More positions owned by Hillhouse Capital Advisors

Pdd Holdings Sponsored Ads (PDD)
Alibaba Group Hldg Sponsored Ads (BABA)
Futu Hldgs Spon Ads Cl A (FUTU)
Webull Corp Ord Shs (BULL)
Beone Medicines Sponsored Ads (ONC)
Baidu Spon Adr Rep A (BIDU)
Legend Biotech Corp Sponsored Ads (LEGN)
Netease Sponsored Ads (NTES)
Arrivent Biopharma (AVBP)
Ke Hldgs Sponsored Ads (BEKE)
Full Truck Alliance Sponsored Ads (YMM)
Yatsen Hldg Sponsored Ads (YSG)
Sea Sponsord Ads (SE)
Clearwater Analytics Hldgs I Cl A (CWAN)
Cytek Biosciences (CTKB)

View all positions for Hillhouse Capital Advisors

Top funds holding Contineum Therapeutics

RA Capital Management
Johnson & Johnson
Suvretta Capital Management
Franklin Resources
Vanguard Group
Balyasny Asset Management
FMR
Sectoral Asset Management
Perceptive Advisors
Hillhouse Capital Advisors
Millennium Management
Red Tree Management
Samsara BioCapital
Versant Venture Management
Point72 Asset Management

View all funds holding Contineum Therapeutics